文献速递慢病管理预防保健、筛查与疫苗

评估初级保健质量改进项目对心血管疾病风险的降低作用:EvidenceNOW研究发现

Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW.
PubMed 文献 · J Am Board Fam Med · 2023-05-11

本研究通过分析模型估算EvidenceNOW多州倡议(2015-2017年,1278家初级保健实践)对10年动脉粥样硬化性心血管疾病(ASCVD)风险的影响,结合2015-2016年NHANES中40-79岁人群数据(n=1295)及风险预测方程。

要点

  • EvidenceNOW干预使平均10年ASCVD风险从10.11%降至10.03%,绝对风险降低0.08。
  • 小规模预防保健改善可在人群层面产生有意义的救命效益。

核心结论

  • 小型预防保健改善及相关的绝对ASCVD风险降低可在人群层面带来有意义的救命效益。

研究设计与样本

  • 分析模型研究,结合1278家EvidenceNOW实践(2015-2017年)数据、2015-2016年NHANES中40-79岁个体信息(n=1295)及10年ASCVD风险预测方程。

主要发现

  • 这些患者干预前平均10年ASCVD风险为10.11%,干预后降至10.03%(绝对风险降低-0.08,P≤.001)。

临床怎么用

  • 在小型初级保健实践中实施ABCS干预(阿司匹林处方、血压控制、胆固醇管理、吸烟筛查与戒烟咨询)可小幅降低10年ASCVD风险。
  • 即使绝对风险降低幅度小,在人群层面仍可带来显著的事件预防和费用节省。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study estimates reductions in 10-year atherosclerotic cardiovascular disease (ASCVD) risk associated with EvidenceNOW, a multi-state initiative that sought to improve cardiovascular preventive care in the form of (A)spirin prescribing for high-risk patients, (B)lood pressure control for people with hypertension, (C)holesterol management, and (S)moking screening and cessation counseling (ABCS) among small primary care practices by providing supportive interventions such as practice facilitation. DESIGN: We conducted an analytic modeling study that combined (1) data from 1,278 EvidenceNOW practices collected 2015 to 2017; (2) patient-level information of individuals ages 40 to 79 years who participated in the 2015 to 2016 National Health and Nutrition Examination Survey (n = 1,295); and (3) 10-year ASCVD risk prediction equations. MEASURES: The primary outcome measure was 10-year ASCVD risk. RESULTS: EvidenceNOW practices cared for an estimated 4 million patients ages 40 to 79 who might benefit from ABCS interventions. The average 10-year ASCVD risk of these patients before intervention was 10.11%. Improvements in ABCS due to EvidenceNOW reduced their 10-year ASCVD risk to 10.03% (absolute risk reduction: -0.08, P ≤ .001). This risk reduction would prevent 3,169 ASCVD events over 10 years and avoid $150 million in 90-day direct medical costs. CONCLUSION: Small preventive care improvements and associated reductions in absolute ASCVD risk levels can lead to meaningful life-saving benefits at the population level.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Lindner SR, Balasubramanian B, Marino M, et al. Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW. J Am Board Fam Med. 2023. PMID: 37169589. doi:10.3122/jabfm.2022.220331R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。